Table 2.
Oral anticoagulants and their metabolism pathways.
| Hepatic Metabolization (%) | Renal Excretion (%) | |
|---|---|---|
| Warfarin | 100% | 0 |
| Apixaban | 75% | 25% |
| Rivaroxaban | 65% | 35% |
| Edoxaban | 50% | 50% |
| Dabigatran | 20% | 80% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.